Filing Details

Accession Number:
0001213900-18-009659
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-25 19:55:50
Reporting Period:
2018-07-23
Accepted Time:
2018-07-25 19:55:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI Pharmaceutical Preparations (2834) 263931704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590232 Ltd Chione Simou Menardou 5,
Kifisia Court, Office 225
6015 Larnaca G4 CY
No No Yes No
1591256 Andreas Hadjimichael Simou Menardou 5,
Kifisia Court, Office 225
6015 Larnaca G4 00000
No No Yes No
1591274 Wiaczeslaw Smolokowski Chalet Lenotchka Ch.de Barnoud
1885 Chesieres
Switzerland G4 00000
No No Yes No
1591275 Marcin Czernik Simou Menardou 5,
Kifisia Court, Office 225
6015 Larnaca G4 00000
No No Yes No
1674499 George Hadjimichael Simou Menardou 5,
Kifisia Court, Office 225
6015 Larnaca G4 00000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-07-23 20,000 $18.66 8,353,178 No 4 S Direct
Common Stock Disposition 2018-07-24 9,144 $18.63 8,344,034 No 4 S Direct
Common Stock Disposition 2018-07-25 895 $18.52 8,343,139 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The prices reported in Column 4 are weighted average prices. The shares were sold on 07/23/2018 at prices ranging from $18.47 to $18.91, inclusive, on 07/24/2018 at prices ranging from $18.6 to $18.72, inclusive, and on 07/25/2018 at prices ranging from $18.5 to $18.59, inclusive.
  2. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 above.
  3. Shares of Common Stock are owned directly by Chione Limited ("Chione"). Chione's directors, Marcin Czernik, Andreas Hadjimichael and George Hadjimichael, may be deemed to share voting and investment power and beneficial ownership of the shares of Common Stock directly owned by Chione. Wiaczeslaw Smolokowski, the sole shareholder of Chione, may also be deemed to share voting and investment power and beneficial ownership of the shares of Common Stock directly owned by Chione.
  4. Each reporting person states that neither the filing of this Form 4 nor anything herein shall be deemed an admission that such person or any other person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Act"), or otherwise, the beneficial owner of any securities covered by this Form 4. Beneficial ownership of the securities covered by this statement is disclaimed.
  5. Each reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Act. Each reporting person declares that neither the filing of this Form 4 nor anything herein shall be construed as an admission that such person or any other person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.